Baird Medical Investment Holdings Limited's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Baird Medical Investment Holdings Limited (BDMD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Baird Medical Investment Holdings Limited vs Its Competitors
- TTM: Trailing 12-month revenue of 22M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
- Scale: Baird Medical Investment Holdings Limited ranks #161 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.0% of industry market cap.
- Peer revenue share: Baird Medical Investment Holdings Limited accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BDMD Sales vs. its Competitors, Q4 2025
Baird Medical Investment Holdings Limited generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs -40.3% for Baird Medical Investment Holdings Limited. Baird Medical Investment Holdings Limited's share of combined industry revenue moved from 0.04% to 0.02%, a loss of 0.02 percentage points.
Baird Medical Investment Holdings Limited's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Baird Medical Investment Holdings Limited | - | No | No | Yes |
| High-Confidence Competitors (1) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
BDMD Stock Performance relative to its Competitors
BDMD Stock Performance relative to High-Confidence Competitors
BDMD Stock Performance relative to Similar-Size Competitors
Baird Medical Investment Holdings Limited's Comment on Competition and Industry Peers
Baird Medical Investment Holdings Limited's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Canyon Medical | Named by the company | 85% |
| ECO Medical | Named by the company | 85% |
| Vison Medical | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Baird Medical Investment Holdings Limited's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.